- Home
- Publications
- Publication Search
- Publication Details
Title
Glycation and Insulin Resistance
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 32, Issue 8, Pages 1760-1765
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-07-19
DOI
10.1161/atvbaha.111.241877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemotactic Activity of S100A7 (Psoriasin) Is Mediated by the Receptor for Advanced Glycation End Products and Potentiates Inflammation with Highly Homologous but Functionally Distinct S100A15
- (2014) R. Wolf et al. JOURNAL OF IMMUNOLOGY
- Glyoxalase 1 increases anxiety by reducing GABAA receptor agonist methylglyoxal
- (2012) Margaret G. Distler et al. JOURNAL OF CLINICAL INVESTIGATION
- Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
- (2011) Ravichandran Ramasamy et al. Annals of the New York Academy of Sciences
- Insulin glycation by methylglyoxal results in native-like aggregation and inhibition of fibril formation
- (2011) Luis MA Oliveira et al. BMC BIOCHEMISTRY
- Serum advanced glycation end products (AGEs) are associated with insulin resistance
- (2011) Kathryn C. B. Tan et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Methylglyoxal impairs insulin signalling and insulin action on glucose-induced insulin secretion in the pancreatic beta cell line INS-1E
- (2011) F. Fiory et al. DIABETOLOGIA
- An Invertebrate Hyperglycemic Model for the Identification of Anti-Diabetic Drugs
- (2011) Yasuhiko Matsumoto et al. PLoS One
- Inhibition of the receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells
- (2010) Yunxia Zhu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
- (2010) Nobuhiro Tahara et al. Cardiovascular Therapeutics
- Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
- (2010) Nina Reiniger et al. DIABETES
- Pyridoxamine, an Inhibitor of Advanced Glycation End Product (AGE) Formation Ameliorates Insulin Resistance in Obese, Type 2 Diabetic Mice
- (2010) Hiroyuki Unoki-Kubota et al. PROTEIN AND PEPTIDE LETTERS
- Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague–Dawley rats
- (2009) Qi Guo et al. JOURNAL OF HYPERTENSION
- “Blinding” of AMP-dependent kinase by methylglyoxal: A mechanism that allows perpetuation of hepatic insulin resistance?
- (2009) A. Gugliucci MEDICAL HYPOTHESES
- S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
- (2008) John H. Boyd et al. CIRCULATION RESEARCH
- Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)
- (2008) Evanthia Diamanti-Kandarakis et al. CLINICAL ENDOCRINOLOGY
- In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEs
- (2008) Angela Cassese et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started